ALPHARETTA, Ga. , Jan. 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will present at the 43 rd Annual J.P. Morgan Healthcare Conference in San Francisco, California , on Monday, Jan. 13 , at approximately 3:45 p.m. PST. A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be... Read More

ALPHARETTA, Ga. , Nov. 12, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in an analyst-led fireside chat at the Stifel 2024 Healthcare Conference at the Lotte New York Palace in New York on Tuesday, Nov. 19 at approximately 3:35 p.m. ET . A webcast of the conference presentation will be available on the Investors section of the... Read More

ALPHARETTA, Ga. , Nov. 11, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has issued its final Medicare Hospital Outpatient Prospective Payment System (OPPS) and Medicare Ambulatory Surgical Center (ASC) Payment System rule for 2025. This rule, effective Jan. 1, 2025 , implements the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act that... Read More

ALPHARETTA, Ga. , Nov. 8, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in a fireside chat at the UBS 2024 Healthcare Conference on Tues., Nov. 12 at approximately 2:45 p.m. Pacific Time. A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that... Read More

Advancement to reduce dislodgement in feeding tube retention systems ALPHARETTA, Ga. , Nov. 5, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the launch of its newly designed CORGRIP SR Nasogastric/Nasointestinal Tube Retention System, further expanding its comprehensive Enteral Feeding portfolio. The new CORGRIP SR system, featuring a monofilament thread, is a nasal bridle solution designed to offer... Read More

ALPHARETTA, Ga. , Oct. 30, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2024 financial results and announced the retirement of its CEO, Joe Woody . Gary Blackford , Avanos Board Chairman, noted, "Joe has decided to retire after leading Avanos for the past seven years. Joe has agreed to assist the Company in the transition of leadership, and will continue to consult with the Company... Read More

ALPHARETTA, Ga. , Oct. 23, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2024 on Wednesday, Oct. 30 at 9 a.m., ET . The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody , chief executive officer, and Michael Greiner ,... Read More

ALPHARETTA, Ga. , Sept. 9, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at CL King's virtual 22 nd Annual Best Ideas Conference 2024 on Mon., Sept. 16 at approximately 9:30 a.m. Eastern Time. A webcast of the conference presentation will be available on the... Read More

New Collaboration Marks GAME READY as the Official Recovery Partner of One of the NFL's Top Defensive Players ALPHARETTA, Ga. , Sept. 9, 2024 /PRNewswire/ -- GAME READY, an Avanos Medical, Inc. (NYSE: AVNS) brand and a leader in innovative injury treatment and recovery technology, is proud to announce its new partnership* with NFL defensive end and San Francisco 49ers star, Nick Bosa . As part of this exciting collaboration,... Read More

ALPHARETTA, Ga. , July 31, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2024 financial results. "We are pleased with our second quarter results and the cumulative progress we have made at the mid-year point," said Joe Woody , Avanos's chief executive officer. Woody continued, "Digestive Health continues to lead in delivering high-single digit growth while Pain Management and Recovery... Read More

ALPHARETTA, Ga. , July 24, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2024 on Wednesday, July 31 at 9 a.m., ET . The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody , chief executive officer, and Michael Greiner... Read More

ALPHARETTA, Ga. , July 1, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Indrani Franchini has been appointed as a new independent member of the Avanos board of directors. "We are excited to welcome Indrani Franchini to the Avanos board," remarked Gary Blackford , Avanos board chair. "Her experience with a broad range of global companies will be invaluable to Avanos as we pursue our vision of... Read More

ALPHARETTA, Ga. , May 13, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Sigfrido (Sig) Delgado has been appointed senior vice president, integrated supply chain. In this role, Delgado will lead the teams focused on implementing continuous improvements within the Company's end-to-end supply chain capabilities worldwide. Delgado joins Avanos from Jabil Healthcare, the industry's largest global... Read More

ALPHARETTA, Ga. , May 2, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2024 financial results. "As we begin the second year of our three-year transformation initiative, we are pleased with our first quarter results," said Joe Woody , Avanos's chief executive officer. Woody added, "We continue to make progress on our long-term margin expansion targets, are delivering on our Digestive... Read More

ALPHARETTA, Ga. , April 25, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET . The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody , chief executive officer, and Michael Greiner ,... Read More

ALPHARETTA, Ga. , Feb. 21, 2024 /PRNewswire/ -- In direct response to the Nurse Assist, LLC voluntary recall of pre-filled syringes and other sterile water products, Avanos Medical, Inc. (NYSE: AVNS) voluntarily recalled specific lots of MIC* Gastric – Jejunal Feeding Tube Kits on Jan. 16, 2024 . These kits include Nurse Assist supplied syringes, pre-filled with sterile water, essential for inflating the retention balloon of... Read More

ALPHARETTA, Ga. , Feb. 20, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2023 results. "We were very pleased with the overall execution on our transformation initiative last year, which sets the foundation for more profitable growth in 2024 and for reaching our mid-term financial targets in 2025," said Joe Woody , Avanos's chief executive officer. Woody continued, "We... Read More

ALPHARETTA, Ga. , Feb. 13, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2023 on Tuesday, Feb. 20 at 9 a.m., ET . The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody , chief executive officer, and... Read More

ALPHARETTA, Ga. , Jan. 4, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported selected, unaudited preliminary financial results for the fourth quarter and full-year ended December 31, 2023 and revised its preliminary revenue outlook for 2024. Preliminary Unaudited Financial Results For the fourth quarter ended December 31, 2023 , Avanos Medical, Inc. (the "Company") expects net sales in the range of $170... Read More

ALPHARETTA, Ga. , Jan. 2, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 42 nd Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, Jan. 8 at approximately 3:45 p.m., PST. A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that... Read More

ALPHARETTA, Ga. , Nov. 7, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner , senior vice president, chief financial officer, and chief transformation officer, will participate in an analyst-led fireside chat at the Stifel 2023 Healthcare Conference on Tuesday, Nov. 14 at approximately 10:20 a.m. ET . A webcast of the conference presentation... Read More

Strong Free Cash Flow Generation in Excess of $25 Million ALPHARETTA, Ga. , Nov. 1, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2023 financial results. "We are pleased with our results for this quarter as we continue to deliver above-market growth in our Digestive Health markets," said Joe Woody , Avanos's chief executive officer. Woody continued, "We believe we are poised to sustain... Read More

ALPHARETTA, Ga. , Oct. 25, 2023 /PRNewswire/ -- Avanos Medical, Inc. ( NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2023 on Wednesday, Nov. 1 at 9 a.m., ET . The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody , chief executive officer, and Michael Greiner ,... Read More

ALPHARETTA, Ga. , Sept. 12, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at CL King's virtual 21 st Annual Best Ideas Conference 2023 on Mon., Sept. 18 at approximately 8:45 a.m. Eastern Time. A webcast of the conference presentation will be available on the... Read More

ALPHARETTA, Ga. , Aug. 9, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2023 financial results. "We posted solid second quarter earnings, with Digestive Health continuing to deliver above-market growth and expanded margins," stated Joe Woody , Avanos's chief executive officer. Woody continued, "Separately, we continue to deliver on our transformation priorities and remain highly focused... Read More

ALPHARETTA, Ga. , Aug. 8, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at the UBS MedTech, Tools and Genomics Summit 2023 on Tues., Aug. 15 at approximately 1:00 p.m. Pacific Time. A webcast of the conference presentation will be available on the Investors... Read More

ALPHARETTA, Ga. , Aug. 2, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2023 on Wednesday, Aug. 9 at 9 a.m., ET . The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody , chief executive officer, and Michael Greiner ,... Read More

New guidance supports use of radiofrequency ablation for osteoarthritic knee pain ALPHARETTA, Ga. , June 28, 2023 /PRNewswire/ -- Avanos Medical supports the announcement today from the UK's National Institute for Health and Care Excellence (NICE) recommending the use of radiofrequency ablation (RFA) for the treatment of osteoarthritic knee pain. From the NICE announcement: "Radiofrequency energy is used to denervate the... Read More

Unique tined-probe technology further differentiates Avanos portfolio ALPHARETTA, Ga. , June 19, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced it has entered into a definitive agreement to acquire Diros Technology Inc., a leading manufacturer of innovative radiofrequency (RF) products used to treat chronic pain conditions. Based in Toronto, Canada , Diros Technology has been at the forefront of... Read More

ALPHARETTA, Ga. , June 13, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it will host an Investor Day at Convene on 101 Park Avenue, New York , on Tuesday, June 20th, 2023 . Chief Executive Officer Joe Woody , and SVP, Chief Financial Officer and Chief Transformation Officer, Michael Greiner , along with key members of Avanos' senior management team, will discuss the company's commercial... Read More

ALPHARETTA, Ga. , June 8, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced it has entered into a definitive agreement to sell its Respiratory Health (RH) business to SunMed Group Holdings, LLC (SunMed). Headquartered in Grand Rapids, Michigan , SunMed is a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care with a comprehensive product... Read More

ALPHARETTA, Ga. , May 3, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2023 financial results. "Our first quarter results were mixed, with our digestive health portfolio continuing to outperform, strong adjusted earnings per share and continued margin improvement partially offset by our results in our pain portfolio," stated Joe Woody , Avanos's chief executive officer. Woody continued,... Read More

ALPHARETTA, Ga. , April 26, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2023 on Wednesday, May 3 at 9 a.m., ET . The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody , chief executive officer, and Michael Greiner ,... Read More

ALPHARETTA, Ga. , March 15, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer and chief transformation officer, will present and participate in an analyst-led fireside chat at the 2023 virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Wed., March 22 at approximately 9:45 a.m., ET. A webcast of the conference... Read More

ALPHARETTA, Ga. , March 6, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dr. Lisa Egbuonu-Davis , currently vice president, medical innovations, for DH Diagnostics, LLC, an affiliate of Danaher Corporation, has been appointed as a new independent member of the Avanos board of directors and will serve as a member of the compliance and governance committees. "We are pleased and excited to welcome... Read More

ALPHARETTA, Ga. , Jan. 11, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced two executive leadership appointments that support the company's long-term strategic priorities: Michael Greiner has been named chief transformation officer (in addition to his current responsibilities as senior vice president and chief financial officer), and Kerr Holbrook has been named senior vice president and chief... Read More

ALPHARETTA, Ga. , Jan. 4, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California on Wednesday, Jan. 11 at approximately 4:30 p.m., PST. A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on... Read More